267 related articles for article (PubMed ID: 22409425)
1. Matrix metalloprotease 2-responsive multifunctional liposomal nanocarrier for enhanced tumor targeting.
Zhu L; Kate P; Torchilin VP
ACS Nano; 2012 Apr; 6(4):3491-8. PubMed ID: 22409425
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity.
Koren E; Apte A; Jani A; Torchilin VP
J Control Release; 2012 Jun; 160(2):264-73. PubMed ID: 22182771
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase 2-sensitive multifunctional polymeric micelles for tumor-specific co-delivery of siRNA and hydrophobic drugs.
Zhu L; Perche F; Wang T; Torchilin VP
Biomaterials; 2014 Apr; 35(13):4213-22. PubMed ID: 24529391
[TBL] [Abstract][Full Text] [Related]
4. "SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers.
Sawant RM; Hurley JP; Salmaso S; Kale A; Tolcheva E; Levchenko TS; Torchilin VP
Bioconjug Chem; 2006; 17(4):943-9. PubMed ID: 16848401
[TBL] [Abstract][Full Text] [Related]
5. Environment-responsive multifunctional liposomes.
Kale AA; Torchilin VP
Methods Mol Biol; 2010; 605():213-42. PubMed ID: 20072884
[TBL] [Abstract][Full Text] [Related]
6. Development of the novel PEG-PE-based polymer for the reversible attachment of specific ligands to liposomes: synthesis and in vitro characterization.
Biswas S; Dodwadkar NS; Sawant RR; Torchilin VP
Bioconjug Chem; 2011 Oct; 22(10):2005-13. PubMed ID: 21870873
[TBL] [Abstract][Full Text] [Related]
7. An efficient PEGylated liposomal nanocarrier containing cell-penetrating peptide and pH-sensitive hydrazone bond for enhancing tumor-targeted drug delivery.
Ding Y; Sun D; Wang GL; Yang HG; Xu HF; Chen JH; Xie Y; Wang ZQ
Int J Nanomedicine; 2015; 10():6199-214. PubMed ID: 26491292
[TBL] [Abstract][Full Text] [Related]
8. Enhancing cancer targeting and anticancer activity by a stimulus-sensitive multifunctional polymer-drug conjugate.
Tu Y; Zhu L
J Control Release; 2015 Aug; 212():94-102. PubMed ID: 26113423
[TBL] [Abstract][Full Text] [Related]
9. Enhanced transfection of tumor cells in vivo using "Smart" pH-sensitive TAT-modified pegylated liposomes.
Kale AA; Torchilin VP
J Drug Target; 2007; 15(7-8):538-45. PubMed ID: 17671900
[TBL] [Abstract][Full Text] [Related]
10. Programmed packaging of mesoporous silica nanocarriers for matrix metalloprotease 2-triggered tumor targeting and release.
Zou Z; He X; He D; Wang K; Qing Z; Yang X; Wen L; Xiong J; Li L; Cai L
Biomaterials; 2015 Jul; 58():35-45. PubMed ID: 25941780
[TBL] [Abstract][Full Text] [Related]
11. "Smart" drug carriers: PEGylated TATp-modified pH-sensitive liposomes.
Kale AA; Torchilin VP
J Liposome Res; 2007; 17(3-4):197-203. PubMed ID: 18027240
[TBL] [Abstract][Full Text] [Related]
12. Efficient delivery of payload into tumor cells in a controlled manner by TAT and thiolytic cleavable PEG co-modified liposomes.
Kuai R; Yuan W; Qin Y; Chen H; Tang J; Yuan M; Zhang Z; He Q
Mol Pharm; 2010 Oct; 7(5):1816-26. PubMed ID: 20701288
[TBL] [Abstract][Full Text] [Related]
13. Building Stable MMP2-Responsive Multifunctional Polymeric Micelles by an All-in-One Polymer-Lipid Conjugate for Tumor-Targeted Intracellular Drug Delivery.
Yao Q; Dai Z; Hoon Choi J; Kim D; Zhu L
ACS Appl Mater Interfaces; 2017 Sep; 9(38):32520-32533. PubMed ID: 28870072
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte-targeting and tumor microenvironment-responsive liposomes for enhanced anti-hepatocarcinoma efficacy.
Cheng D; Wen Z; Chen H; Lin S; Zhang W; Tang X; Wu W
Drug Deliv; 2022 Dec; 29(1):2995-3008. PubMed ID: 36104946
[TBL] [Abstract][Full Text] [Related]
15. Increased tumor targeted delivery using a multistage liposome system functionalized with RGD, TAT and cleavable PEG.
Mei L; Fu L; Shi K; Zhang Q; Liu Y; Tang J; Gao H; Zhang Z; He Q
Int J Pharm; 2014 Jul; 468(1-2):26-38. PubMed ID: 24709209
[TBL] [Abstract][Full Text] [Related]
16. Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors.
McNeeley KM; Karathanasis E; Annapragada AV; Bellamkonda RV
Biomaterials; 2009 Aug; 30(23-24):3986-95. PubMed ID: 19427688
[TBL] [Abstract][Full Text] [Related]
17. Intelligent "Peptide-Gathering Mechanical Arm" Tames Wild "Trojan-Horse" Peptides for the Controlled Delivery of Cancer Nanotherapeutics.
Shi NQ; Li Y; Zhang Y; Shen N; Qi L; Wang SR; Qi XR
ACS Appl Mater Interfaces; 2017 Dec; 9(48):41767-41781. PubMed ID: 29161013
[TBL] [Abstract][Full Text] [Related]
18. An aptamer ligand based liposomal nanocarrier system that targets tumor endothelial cells.
Ara MN; Matsuda T; Hyodo M; Sakurai Y; Hatakeyama H; Ohga N; Hida K; Harashima H
Biomaterials; 2014 Aug; 35(25):7110-20. PubMed ID: 24875764
[TBL] [Abstract][Full Text] [Related]
19. Targeting and microenvironment-responsive lipid nanocarrier for the enhancement of tumor cell recognition and therapeutic efficiency.
Gao W; Meng T; Shi N; Zhuang H; Yang Z; Qi X
Adv Healthc Mater; 2015 Apr; 4(5):748-59. PubMed ID: 25522298
[TBL] [Abstract][Full Text] [Related]
20. Multifunctional Micellar Nanocarriers for Tumor-Targeted Delivery of Hydrophobic Drugs.
Dai Z; Tu Y; Zhu L
J Biomed Nanotechnol; 2016 Jun; 12(6):1199-210. PubMed ID: 27319214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
